In a Haemophilia Centre Directors' Hepatitis Working Party report, Dr Craske concluded that "there remains much work to be done to devise methods to prevent the threat of chronic liver disease clouding the undoubted benefits that large pool concentrates have brought." Read more about In a Haemophilia Centre Directors' Hepatitis Working Party report, Dr Craske concluded that "there remains much work to be done to devise methods to prevent the threat of chronic liver disease clouding the undoubted benefits that large pool concentrates have brought."
Dr Craske produced a report of the Haemophilia Directors Hepatitis Working Party, which presented evidence of specific protection conferred by a previous batch of Hemofil against contracting Non-A Non-B Hepatitis. Read more about Dr Craske produced a report of the Haemophilia Directors Hepatitis Working Party, which presented evidence of specific protection conferred by a previous batch of Hemofil against contracting Non-A Non-B Hepatitis.
At a Haemophilia Reference Centre Directors meeting, Professor Edward Blackburn observed that "It seems that the Radio and Television authorities have the right to edit and comment on their presentations as they think fit." Read more about At a Haemophilia Reference Centre Directors meeting, Professor Edward Blackburn observed that "It seems that the Radio and Television authorities have the right to edit and comment on their presentations as they think fit."
Dr Craske gave a talk entitled Virus hepatitis complicating replacement therapy at the Symposium on Haemophilia. Read more about Dr Craske gave a talk entitled Virus hepatitis complicating replacement therapy at the Symposium on Haemophilia.
Professor Gordon Lowe first heard NANBH being discussed at a conference in Glasgow in 1975 where Dr Craske (UKHCDO Hepatitis Working Party Chairman) was a speaker - "I remember him saying that it wasn't only hepatitis B, you could get hepatitis from non-A, non-B." Read more about Professor Gordon Lowe first heard NANBH being discussed at a conference in Glasgow in 1975 where Dr Craske (UKHCDO Hepatitis Working Party Chairman) was a speaker - "I remember him saying that it wasn't only hepatitis B, you could get hepatitis from non-A, non-B."
In oral evidence to the Inquiry Professor Gordon Lowe stated that the age of hospital transfer of children was "left very much to the haemophilia director at Yorkhill to decide...it was very much up to the children's director to decide...they would have a discussion with the adult centre and then often a joint review, usually at Yorkhill". Read more about In oral evidence to the Inquiry Professor Gordon Lowe stated that the age of hospital transfer of children was "left very much to the haemophilia director at Yorkhill to decide...it was very much up to the children's director to decide...they would have a discussion with the adult centre and then often a joint review, usually at Yorkhill".
Dr Craske and others published a journal article in The Lancet about an outbreak of Hepatitis A and B in patients with haemophilia in Bournemouth who had been given commercial factor 8 concentrate. He suggested that "commercial factor VIII concentrates should be reserved for the treatment of life-threatening bleeds in all haemophiliacs and for covering major operations". Read more about Dr Craske and others published a journal article in The Lancet about an outbreak of Hepatitis A and B in patients with haemophilia in Bournemouth who had been given commercial factor 8 concentrate. He suggested that "commercial factor VIII concentrates should be reserved for the treatment of life-threatening bleeds in all haemophiliacs and for covering major operations".
In a paper titled "Jaundice and factor VIII antibodies in treated patients with haemophilia and Christmas disease" a suggestion was made that "Perhaps now that the virus associated Australian antigen can be studied a method will be found to remove that antigen from concentrated materials". The paper's authors concluded that "We feel that the increased risk of clinical illness is not so great a to overbalance the advantages of the use of concentrates". Read more about In a paper titled "Jaundice and factor VIII antibodies in treated patients with haemophilia and Christmas disease" a suggestion was made that "Perhaps now that the virus associated Australian antigen can be studied a method will be found to remove that antigen from concentrated materials". The paper's authors concluded that "We feel that the increased risk of clinical illness is not so great a to overbalance the advantages of the use of concentrates".
In a paper by Peter Jones titled "Home Treatment Working Party" 87 haemophilia B patients were recorded as being on home therapy and 65 haemophilia A patients were recorded as receiving prophylaxis in 1978 which was about double the amount of those in 1977. Read more about In a paper by Peter Jones titled "Home Treatment Working Party" 87 haemophilia B patients were recorded as being on home therapy and 65 haemophilia A patients were recorded as receiving prophylaxis in 1978 which was about double the amount of those in 1977.
At the 8th meeting of the UK Haemophilia Centre directors it was recorded that during 1976 that 729 patients had been on home treatment. Read more about At the 8th meeting of the UK Haemophilia Centre directors it was recorded that during 1976 that 729 patients had been on home treatment.